Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
INDUSTRY
×
Nasopharyngeal Neoplasms
×
Clear all
Filters
3
NCT03924986
2025-01-31
RATIONALE-309
BeiGene
Phase 3
Completed
263 enrolled
19 charts
NCT02611960
2023-07-13
Keynote-122
Merck Sharp & Dohme LLC
Phase 3
Completed
233 enrolled
21 charts
NCT02578641
2023-06-28
VANCE
Tessa Therapeutics
Phase 3
Completed
330 enrolled
18 charts